William Blair analyst Myles R. Minter upgraded Neumora Therapeutics (NASDAQ: NMRA) from Market Perform to Outperform.The analyst comments: "We are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE